Fund comparison, Mid Cap Fund
RupeeCase Allcap vs Kotak Emerging Equity Fund
The Allcap model record against the published figures of Kotak Emerging Equity Fund. Allcap is a quantitative index algo you hold in your own demat for 0.2% of the value traded per rebalance; Kotak Emerging Equity is an actively managed fund charging ~1.5% TER on the whole holding each year.
- Allcap CAGR, 5y
- 47.49%Model, back tested, as of 8 Aug 2026
- Kotak Emerging Equity CAGR, 5y
- 14.2%Published, as of 13 Jul 2026
- Allcap max drawdown
- −22.72%Model, as of 13 Jul 2026
- Kotak Emerging Equity max drawdown
- −31.1%Published, as of 13 Jul 2026
- Allcap, model ₹611
- Kotak Emerging Equity, 14.2% CAGR line ₹194
- Nifty 50 TRI, 9.80% CAGR line ₹160
₹100 in the Allcap model in Jul 2021 became ₹611 by Jul 2026, after charges, log scale. Model, back tested, as of 27 Apr 2026. The fund line is a constant growth path at its published 5 year CAGR (as of 13 Jul 2026), not its NAV; the Nifty 50 TRI line is the same for the index. Not a promise of future returns.
01Side by side
Seven figures, each with its source and date.
Allcap: model, back tested, rolling 5 year window, return and minimum capital as of 8 Aug 2026, Sharpe and drawdown as of 13 Jul 2026. Kotak Emerging Equity Fund: publicly available figures as of 13 Jul 2026, rounded from AMC factsheets.
- MetricRupeeCase Allcap, modelKotak Emerging Equity Fund, published
- CAGR, 5 year47.49%14.2%
- Sharpe1.680.74
- Max drawdown−22.72%−31.1%
- Minimum capital₹2,25,000₹5,000 SIP
- Fees0.2% of traded value per rebalance~1.5% TER
- Lock inNone1 year for exit load
- TransparencyFull list at every rebalance, publishedMonthly disclosure
Comparisons use publicly available data as of 13 Jul 2026 and RupeeCase rolling 5 year back test metrics; RupeeCase return and minimum capital figures are as of 8 Aug 2026. Mutual fund metrics rounded from AMC factsheets. A back test is not a live track record. Not investment advice; do your own due diligence. Past performance is not indicative of future results.
02What actually differentiates them
Who holds the shares, what you pay, how it is built, what you can see.
Who holds the shares
Allcap: you do, in your own demat; orders go through your own broker and you approve each rebalance. Kotak Emerging Equity: the scheme holds them; you hold units.
What you pay
Allcap: 0.2% of the value traded at each rebalance, nothing on what stays, nothing when nothing changes, no lock in. Kotak Emerging Equity: ~1.5% TER on the whole holding every year, with an exit load (1 year for exit load).
How it is built
Allcap: a fixed, published rule: 50 momentum names from the Nifty Total Market under ₹5,000, equal weight, rescreened every two weeks. Kotak Emerging Equity: a fund manager's selection within the mid cap fund mandate.
What you can see
Allcap: the full list on every rebalance date, back to 14 May 2021, in the rebalance history. Kotak Emerging Equity: monthly disclosure.
03Where each one sits
Core and satellite, in plain words.
Not advice; a description of what each product is built to do.
- RupeeCase Allcap is built as a rules based momentum core: 50 names across the whole market, rescreened every two weeks, in your own demat, with a minimum of about ₹2,25,000 and the model drawdowns shown above. It suits an investor who wants a published rule and the shares in their own name, and can sit through a momentum drawdown.
- Kotak Emerging Equity Fund is built as a managed mid cap fund with a small ticket (₹5,000 SIP), where the manager's choices and the ~1.5% TER are the trade off. It suits an investor who wants a pooled vehicle and a very small starting amount.
04Questions
Allcap vs Kotak Emerging Equity, in plain words
Is RupeeCase Allcap a mutual fund like Kotak Emerging Equity?
No. Kotak Emerging Equity Fund is a mid cap fund that pools investors' money and holds the shares in the scheme. RupeeCase Allcap is a published index algo: 50 momentum names from the Nifty Total Market at equal weight, rebalanced every two weeks, executed in your own broker account. The shares sit in your own demat; RupeeCase never holds money and is not a fund, PMS or adviser.
Why compare a back test with a fund?
Because that is what each side publishes. Allcap's figures are a model, back tested record (rolling 5 years, as of 8 Aug 2026; Sharpe and drawdown as of 13 Jul 2026); the fund's are its published returns and risk as of 13 Jul 2026, rounded from AMC factsheets. A back test is not a live track record and the two are not like for like; the page labels every figure with its source and date.
What does each one cost?
Kotak Emerging Equity Fund: ~1.5% TER, charged on the whole holding every year, plus an exit load (1 year for exit load). RupeeCase Allcap: 0.2% of the value traded at each rebalance, nothing on what stays, no subscription, AUM fee, performance fee or lock in. The fee calculator works out what that is on your amount over the years.
Hold the index algo in your own demat.
Compare the 18 published model records, validate the back test, then invest; 0.2% of the value traded per rebalance, nothing else.
Model, back tested. As of 8 Aug 2026. Not a fund, PMS or adviser. Not a promise of future returns.